{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:07:39Z","timestamp":1791389259598,"version":"4.3.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002732","name":"AOSpine","doi-asserted-by":"publisher","award":["AOS-DIA-22-012-TUM"],"award-info":[{"award-number":["AOS-DIA-22-012-TUM"]}],"id":[{"id":"10.13039\/501100002732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thespinejournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Spine Journal"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.spinee.2025.03.016","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T10:13:42Z","timestamp":1743156822000},"page":"1371-1385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predicting quality of life of patients after treatment for spinal metastatic disease: development and internal evaluation"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2037-8986","authenticated-orcid":false,"given":"Rene Harmen","family":"Kuijten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Bindels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"Huele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diyar","family":"Delawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Verkooijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorrit Jan","family":"Verlaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Tobert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9452-415X","authenticated-orcid":false,"given":"Joost","family":"Rutges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.spinee.2025.03.016_bib0001","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.spinee.2018.03.011","article-title":"Predicting survival for metastatic spine disease: a comparison of nine scoring systems","volume":"18","author":"Ahmed","year":"2018","journal-title":"Spine J"},{"issue":"4","key":"10.1016\/j.spinee.2025.03.016_bib0002","doi-asserted-by":"crossref","first-page":"E671","DOI":"10.1093\/neuros\/nyz070","article-title":"Predicting 90-day and 1-year mortality in spinal metastatic disease: development and internal validation","volume":"85","author":"Karhade","year":"2019","journal-title":"Clin Neurosurg"},{"issue":"4","key":"10.1016\/j.spinee.2025.03.016_bib0003","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/CORR.0000000000001081","article-title":"External validation of PATHFx Version 3.0 in patients treated surgically and nonsurgically for symptomatic skeletal metastases","volume":"478","author":"Anderson","year":"2020","journal-title":"Clin Orthop Relat Res"},{"issue":"10","key":"10.1016\/j.spinee.2025.03.016_bib0004","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.spinee.2020.05.003","article-title":"Does the SORG algorithm generalize to a contemporary cohort of patients with spinal metastases on external validation?","volume":"20","author":"Bongers","year":"2020","journal-title":"The Spine J"},{"key":"10.1016\/j.spinee.2025.03.016_bib0005","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.wneu.2020.03.098","article-title":"A personalized medicine approach for the management of spinal metastases with cord compression: development of a novel clinical prediction model for postoperative survival and quality of life","volume":"140","author":"Nater","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.spinee.2025.03.016_bib0006","doi-asserted-by":"crossref","first-page":"101856","DOI":"10.1016\/j.canep.2020.101856","article-title":"Gender disparities in clinical presentation, treatment, and outcomes in metastatic spine disease","volume":"70","author":"Price","year":"2021","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.spinee.2025.03.016_bib0007","doi-asserted-by":"crossref","first-page":"107581","DOI":"10.1016\/j.clineuro.2022.107581","article-title":"Analysis of socioeconomic and demographic factors on post-treatment outcomes for metastatic spinal tumors","volume":"225","author":"Larkin","year":"2023","journal-title":"Clin Neurol Neurosurg."},{"key":"10.1016\/j.spinee.2025.03.016_bib0008","doi-asserted-by":"crossref","first-page":"101792","DOI":"10.1016\/j.canep.2020.101792","article-title":"Racial disparities in clinical presentation, type of intervention, and in-hospital outcomes of patients with metastatic spine disease: an analysis of 145,809 admissions in the United States","volume":"68","author":"De la Garza Ramos","year":"2020","journal-title":"Cancer Epidemiol"},{"issue":"19","key":"10.1016\/j.spinee.2025.03.016_bib0009","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1002\/cncr.27388","article-title":"The impact of insurance status on outcomes after surgery for spinal metastases","volume":"118","author":"Dasenbrock","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.spinee.2025.03.016_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.spinee.2025.03.016_bib0011","first-page":"2356497","article-title":"Prospective evaluation of interventional studies on bone metastases - the PRESENT cohort (PRESENT)","volume":"6","author":"Verkooijen","year":"2013","journal-title":"Clinical Trials Gov"},{"issue":"12","key":"10.1016\/j.spinee.2025.03.016_bib0012","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1007\/s00586-020-06599-x","article-title":"The importance of timely treatment for quality of life and survival in patients with symptomatic spinal metastases","volume":"29","author":"van Tol","year":"2020","journal-title":"Eur Spine J"},{"key":"10.1016\/j.spinee.2025.03.016_bib0013","unstructured":"AO Innovation Translation Center Metastatic Tumor Research and Outcomes Network (MTRON) Clinical Trials Gov. 2016; 7,2830451 https:\/\/clinicaltrials.gov\/study\/NCT02830451"},{"issue":"1","key":"10.1016\/j.spinee.2025.03.016_bib0014","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1477-7525-5-70","article-title":"Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer","volume":"5","author":"Pickard","year":"2007","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"10.1016\/j.spinee.2025.03.016_bib0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1600-0609.2011.01665.x","article-title":"Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma","volume":"87","author":"Kvam","year":"2011","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.spinee.2025.03.016_bib0016","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-SD: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"issue":"10","key":"10.1016\/j.spinee.2025.03.016_bib0017","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hec.1124","article-title":"The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies","volume":"15","author":"Lamers","year":"2006","journal-title":"Health Econ"},{"key":"10.1016\/j.spinee.2025.03.016_bib0018","author":"Morton"},{"issue":"8","key":"10.1016\/j.spinee.2025.03.016_bib0019","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.arth.2020.03.019","article-title":"Development of machine learning algorithms to predict clinically meaningful improvement for the patient-reported health State after total hip arthroplasty","volume":"35","author":"Kunze","year":"2020","journal-title":"J Arthroplasty"},{"issue":"2","key":"10.1016\/j.spinee.2025.03.016_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171507","article-title":"Symptomatic spinal metastasis: a systematic literature review of the preoperative prognostic factors for survival, neurological, functional and quality of life in surgically treated patients and methodological recommendations for prognostic studies","volume":"12","author":"Nater","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.spinee.2025.03.016_bib0021","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity Index and Score for risk adjustment in Hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.spinee.2025.03.016_bib0022","series-title":"Evaluation of chemotherapeutic agents","first-page":"191","article-title":"The clinical evaluation of chemotherapeutic agents in cancer","author":"Karnofsky","year":"1949"},{"issue":"5","key":"10.1016\/j.spinee.2025.03.016_bib0023","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/cam4.292","article-title":"New prognostic factors and scoring system for patients with skeletal metastasis","volume":"3","author":"Katagiri","year":"2014","journal-title":"Cancer Med"},{"key":"10.1016\/j.spinee.2025.03.016_bib0024","doi-asserted-by":"crossref","unstructured":"Oken M.M. Toxicity and response criteria of the Eastern Cooperative Oncology Group. 1982;5(6):649-656.","DOI":"10.1097\/00000421-198212000-00014"},{"issue":"1","key":"10.1016\/j.spinee.2025.03.016_bib0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","article-title":"Missforest-non-parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"issue":"404","key":"10.1016\/j.spinee.2025.03.016_bib0026","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1080\/01621459.1988.10478722","article-title":"A test of missing completely at random for multivariate data with missing values","volume":"83","author":"Little","year":"1988","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.spinee.2025.03.016_bib0027","doi-asserted-by":"crossref","first-page":"m441","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model","author":"Riley","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.spinee.2025.03.016_bib0028","article-title":"Evaluation of clinical prediction models (part 3): calculating the sample size required for an external validation study","volume":"e074821","author":"Riley","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.spinee.2025.03.016_bib0030","series-title":"Proceedings of the 25th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining","first-page":"2623","article-title":"Optuna","author":"Akiba","year":"2019"},{"issue":"8","key":"10.1016\/j.spinee.2025.03.016_bib0031","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","article-title":"Internal validation of predictive models","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"29","key":"10.1016\/j.spinee.2025.03.016_bib0032","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/eurheartj\/ehu207","article-title":"Towards better clinical prediction models: seven steps for development and an ABCD for validation","volume":"35","author":"Steyerberg","year":"2014","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.spinee.2025.03.016_bib0033","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ejca.2008.11.013","article-title":"The European Organisation for Research and Treatment of Cancer Quality of life questionnaire for patients with bone metastases: the EORTC QLQ-BM22","volume":"45","author":"Chow","year":"2009","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.spinee.2025.03.016_bib0034","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jclinepi.2009.12.008","article-title":"Missing covariate data in medical research: to impute is better than to ignore","volume":"63","author":"Janssen","year":"2010","journal-title":"J Clin Epidemiol."},{"issue":"4","key":"10.1016\/j.spinee.2025.03.016_bib0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s11136-014-0837-y","article-title":"Multiple imputation to deal with missing EQ-5D-3L data: should we impute individual domains or the actual index?","volume":"24","author":"Simons","year":"2015","journal-title":"Quality Life Res"},{"issue":"22","key":"10.1016\/j.spinee.2025.03.016_bib0036","doi-asserted-by":"crossref","first-page":"E1221","DOI":"10.1097\/BRS.0b013e3181e16ae2","article-title":"A novel classification system for spinal instability in neoplastic disease","volume":"35","author":"Fisher","year":"2010","journal-title":"Spine (Phila Pa 1976)"},{"issue":"3","key":"10.1016\/j.spinee.2025.03.016_bib0037","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3171\/2010.3.SPINE09459","article-title":"Reliability analysis of the epidural spinal cord compression scale","volume":"13","author":"Bilsky","year":"2010","journal-title":"J Neurosurg Spine"},{"issue":"6","key":"10.1016\/j.spinee.2025.03.016_bib0038","doi-asserted-by":"crossref","first-page":"100320","DOI":"10.1016\/j.esmoop.2021.100320","article-title":"Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs","volume":"6","author":"Franken","year":"2021","journal-title":"ESMO Open"}],"container-title":["The Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943025001615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943025001615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T23:40:39Z","timestamp":1750290039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529943025001615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1529943025001615"],"URL":"https:\/\/doi.org\/10.1016\/j.spinee.2025.03.016","relation":{},"ISSN":["1529-9430"],"issn-type":[{"value":"1529-9430","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting quality of life of patients after treatment for spinal metastatic disease: development and internal evaluation","name":"articletitle","label":"Article Title"},{"value":"The Spine Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spinee.2025.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}